Study Highlights Elevated Suicide Risks Among Musicians
Medical Xpress | 3/31/25
An Emory University study published in Frontiers in Public Health has identified significant suicide risks among musicians, shedding light on factors that contribute to the increased risk and highlighting the need for targeted mental health interventions within the music industry.
Sheila Rauch Highlighted as an Emory Female Faculty Rising Star
Emory | 3/26/25
The Emory Alliance for Women in Medicine and Science celebrates Women’s History Month. Sheila Rauch is highlighted as an exceptional rising star for female faculty and staff members at Emory School of Medicine.
Women Trailblazers in Mental Health | An Interview with Barbara Rothbaum
ADAA | 3/10/25
Hear from Dr. Barbara Rothbaum on her decision to pursue a career in mental health, ways to advocate for women in the field, and the qualities that make a leader.
High Suicide Rates Show Music Industry ‘Profoundly Dangerous’, Researchers Say
The Guardian | 3/6/25
“Those working as musicians, actors and entertainers were the highest-risk group within the occupational group defined [by the Office for National Statistics] as culture, media and sport occupations, in which overall the suicide rate for males was 20% higher than the male average and for females was 69% higher,” says the report, which was co-authored by Dr Dorian Lamis, a psychologist at Emory University.
FDA Expands Access to Clozapine for Treatment-Resistant Schizophrenia
Everyday Health | 3/3/25
Even if the new FDA approach to clozapine doesn’t immediately lead to a surge in prescriptions, the potential to access this drug more easily may be truly life-altering for patients, says David Goldsmith, MD, an associate professor of psychiatry at Emory University School of Medicine in Atlanta.
Emory to Expand Research into How Psychedelic Drug can Help Treat PTSD
AJC | 3/3/25
Emory University is poised to expand its research on how MDMA, a psychedelic drug commonly known as ecstasy, could help patients with PTSD when coupled with a proven form of psychotherapy.
Emory Expands PTSD Research with $4.9M DoD-Funded MDMA Study
Emory News Center | 2/28/25
Emory University is collaborating with The University of Texas Health Science Center at San Antonio and its STRONG STAR Consortium in a new clinical trial aimed at improving treatment outcomes for post-traumatic stress disorder.
$4.9 Million Grant Aims to Enhance PTSD Treatment Using MDMA and Psychotherapy
News - Medical Life Sciences | 2/27/25
Researchers at The University of Texas Health Science Center at San Antonio and their collaborators at Emory University have received a $4.9 million grant aimed at significantly improving treatment and recovery rates for individuals suffering from post-traumatic stress disorder.
How Uncertainty Over Federal Health Funding and Data is Affecting Georgia Researchers
Healthbeat Atlanta | 2/12/25
Emory Professor Nadine Kaslow said the survey “provides without a doubt the best information we have in our country” about high school students’ mental and behavioral health. | Georgia Public Broadcasting
How to Motivate Yourself to Exercise if Depression Is Getting in the Way
Everyday Health | 1/28/25
If you have depression, you probably know that exercise can do a lot of good for your symptoms. Plenty of research shows that exercise can boost mood and ease depression. But many find that their symptoms make it hard to work out at all.
Tackling PTSD with Dr. Sheila Rauch of Emory Healthcare
Warrior Alliance Network | 1/24/25
Sheila Rauch, deputy director of the Emory Healthcare Veterans Program and professor of psychiatry and behavioral sciences, sat down with the Warrior Alliance Network to discuss PTSD and mental health treatments and shared insights on effective therapies, the importance of outreach and how every American can support veterans.
Psychedelics May Aid the Spirit and Body
Atlanta Jewish Times | 1/15/25
The first is understanding the spiritual and religious impacts of these powerful interventions that we use. Another is really within the clinical psychology domain, trying to improve the actual psychotherapies that we use that are part of these interventions.